Ditchcarbon
  • Customers
  1. Organizations
  2. TESSA
Public Profile
Pharmaceutical Preparation Manufacturing
FI
updated 10 days ago

TESSA

Company website

TESSA, officially known as TESSA Technologies, is a leading provider of innovative software solutions headquartered in Finland (FI). Founded in 2015, the company has rapidly established itself in the technology sector, focusing on digital transformation and automation services across various industries, including finance, healthcare, and manufacturing. With a commitment to enhancing operational efficiency, TESSA offers a unique suite of products, including advanced data analytics tools and custom software development. These solutions are designed to streamline processes and improve decision-making for businesses of all sizes. TESSA's market position is bolstered by its dedication to quality and customer satisfaction, earning recognition for its impactful contributions to the digital landscape.

DitchCarbon Score

How does TESSA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

52

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

TESSA's score of 52 is higher than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.

72%

Let us know if this data was useful to you

TESSA's reported carbon emissions

In 2024, TESSA reported total carbon emissions of approximately 1,054,000 kg CO2e, comprising 15,000 kg CO2e from Scope 1, 87,000 kg CO2e from Scope 2, and 969,000 kg CO2e from Scope 3 emissions. This reflects a slight decrease in emissions from 2023, where total emissions were about 1,063,000 kg CO2e, with Scope 1 at 13,000 kg CO2e, Scope 2 at 91,000 kg CO2e, and Scope 3 at 1,051,000 kg CO2e. TESSA has set ambitious reduction targets, aiming for an 80% reduction in carbon emissions from both Scope 1 and Scope 2 by 2030, compared to their 2020 levels. This commitment underscores their dedication to mitigating climate impact and aligns with industry standards for sustainability. The emissions data is not cascaded from any parent organization, indicating that TESSA independently reports its carbon footprint. The company continues to focus on enhancing its sustainability practices as part of its corporate responsibility initiatives.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20202021202220232024
Scope 1
52,000
00,000
00,000
00,000
00,000
Scope 2
154,000
000,000
00,000
00,000
00,000
Scope 3
6,313,000
000,000
0,000,000
0,000,000
000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. TESSA's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for TESSA is in FI, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

TESSA is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Mabwell Therapeutics, Inc.

US
Updated 14 days ago

Hisun Pharmaceutical

CN
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Novimmune SA

CH
•
Research and development services (73)
Updated 14 days ago

Shattuck Labs, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Jiangsu Chia Tai-Tianqing Pharmaceutical Co. Ltd

CN
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

ImmuneOnco Biopharmaceuticals (Shanghai) Inc.

CN
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250808.1
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy